Connecting you to content on EBSCOhost

Works by Khatami, Pezhman

Results: 2

Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years.
Published in:
BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08079-1
By:
- Gholami, Fatemeh;
- Hamidi Farahani, Ramin;
- Karimi Rahjerdi, Ahmad;
- Ahi, Mohammadreza;
- Sheidaei, Ali;
- Gohari, Kimiya;
- Rahimi, Zahra;
- Ansarifar, Akram;
- Basiri, Pouria;
- Moradi, Milad;
- Jahangiri, Arash;
- Naderi, Kosar;
- Ghasemi, Soheil;
- Khatami, Pezhman;
- Honari, Mohsen;
- Khodaverdloo, Samane;
- Shooshtari, Mohammad;
- Mehr Azin, Hajar;
- Moradi, Sohrab;
- Shafaghi, Batool
Publication type:
Article
Development of Inactivated FAKHRAVAC ® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models.
Published in:
Vaccines, 2021, v. 9, n. 11, p. 1271, doi. 10.3390/vaccines9111271
By:
- Ghasemi, Soheil;
- Naderi Saffar, Kosar;
- Ebrahimi, Firooz;
- Khatami, Pezhman;
- Monazah, Arina;
- Alizadeh, Ghorban-Ali;
- Ettehadi, Hossein-Ali;
- Rad, Iman;
- Nojehdehi, Shahrzad;
- Kehtari, Mousa;
- Kouhkan, Fatemeh;
- Barjasteh, Hesam;
- Moradi, Sohrab;
- Ghorbani, Mohammad-Hosein;
- Khodaie, Ali;
- Papizadeh, Moslem;
- Najafi, Roghayeh;
- Naghneh, Ehsan;
- Sadeghi, Davood;
- Karimi Rahjerdi, Ahmad
Publication type:
Article